Illumina Inc. (ILMN) receives a Roarable Rating of D+ (Sell) and flashes a Red SELL / AVOID warning (69/100 RQD Confidence). Our SEC filing scanner spotted paper earnings outpacing real operating cash flow (+140.6% (NI vs OCF)) while unpaid customer invoices grew—a classic sign to step aside until cash flow catches up.
Illumina Inc. (ILMN) advanced +0.44% to $290.06 as options desks priced 56% call premium vs. 44% put protection around the $284 max-pain magnet. Accounting Warning: Paper earnings outpaced operating cash flow (+140.6% (NI vs OCF)) as receivables rose.
Shares of genomics company Illumina (NASDAQ:ILMN) fell 17.7% in the afternoon session after the company reported third-quarter 2026 financial results and highlighted impacts from being placed on China's Unreliable Entiti
Ark Invest increased its exposure to several widely followed biotechnology stocks during the session.
Illumina has delivered a powerful move over the past few years, yet the recent pullback puts fresh focus on a simple question for anyone looking at the stock today: do the cash flows behind the business line up with the
Jacob Thaysen says Illumina delivered a strong third quarter, beat expectations and raised its fourth-quarter outlook. He said the company has moved from essentially flat performance to mid-single-digit growth over the p
Illumina (ILMN) has released its third quarter results, reporting US$1.13b in revenue and net income of US$220m, and has raised its full-year 2026 revenue outlook to a range of US$4.64b to US$4.66b. Illumina’s latest gui
S&P 500 top percentage movers in today's US session, led by FDXF gainer and INTC decliner, with gainers and losers ranked by latest prices.
JP Morgan analyst Casey Woodring maintains Illumina (NASDAQ:ILMN) with a Overweight and lowers the price target from $320 to $300.
S&P 500 top movers for today's session include FDXF up 16.16% and INTC down 30.00%, with double-digit gains and losses across the index.
Alphabet logs its worst week since 2011 and Intel its worst day ever as the AI trade cracks, while health care posts a record month against the market.
S&P 500 gap movers on October 30, 2026 included FDXF, VLTO, GILD and INCY on the upside, while INTC, RDDT and TWLO were among the gap-down decliners.
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. -0.7% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on ILMN today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for ILMN. Explore sector supply chains on /butterfly.
Why ILMN Stock advanced +0.44% Today — RQD Quant Desk Flash. Accounting Warning: Paper earnings outpaced operating cash flow (+140.6% (NI vs OCF)) as receivables rose.